Skip to content

Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™

TrueLoo™: Determining the Feasibility of an Electronic Bowel Movement and Urinary Event Log Via In Situ Categorization of Physical Properties of Stool and Urine

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05008640
Enrollment
143
Registered
2021-08-17
Start date
2019-11-14
Completion date
2021-06-18
Last updated
2021-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridium Difficile Infection, GastroIntestinal Bleeding, Gastrointestinal Disease, Infectious Diarrhea, Urinary Tract Infections

Keywords

Geriatric, Gastroenterology, Urinary

Brief summary

The purpose of this study is to assess the feasibility of TrueLoo™, an Internet-connected smart toilet seat, in accurately monitoring and logging bowel movements and urinations of residents in senior living facilities across Northern California.

Detailed description

The logging and monitoring of bowel movements and urinary events is an important aspect of preventative care for residents in senior living facilities, providing early warning signs for conditions that may otherwise cause complications if dealt with reactively. However, this information is sporadically collected - if at all - and subjectively interpreted by caregivers, leading to inconsistencies and unreliable data. Toi Labs, Inc. has created TrueLoo™, an Internet-connected toilet seat, as a solution to these issues. TrueLoo™ acquires time-lapse images of a bowel movement or urinary event automatically and under controlled conditions. Residents enrolled in the current study will have a TrueLoo™ installed in their private bathroom, through which all bowel movements and urinary events will be tracked, anonymously, privately, and securely. As a result, an electronic bowel movement and urinary event log for each enrolled resident will be generated. Given sufficient data, the TrueLoo™ system will complete such electronic logs automatically, identify points in time where particular enrolled residents may have experienced anomalous toileting patterns, and determine the relevance of such events through targeted health history and urine sampling.

Interventions

DEVICETrueLoo™

TrueLoo™ is an Internet-connected, smart toilet seat that uses computer vision technology to log and capture daily bowel movements and urinations. This data is then categorized by physical excreta characteristics to train and develop machine learning algorithms that are intended to eventually identify significant changes in stool and urine in real-time.

Sponsors

Toi Labs, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Must be willing to participate and provide consent for the study; * Must be a male or female, aged 55 or older; * Must be a resident of a senior living facility; * Must have regular access to a TrueLoo™.

Exclusion criteria

* Candidates who are unwilling or unable to accept the requirements associated with installing TrueLoo™ in their residence, including power and Wi-Fi connectivity; * Candidates who use certain types of toileting assistance devices that at this time are not compatible with TrueLoo™ (e.g., padded toilet seat risers).

Design outcomes

Primary

MeasureTime frameDescription
Bowel movement and urinary event dataset creationWeek 16 - 30Number of urinations and bowel movements exhibited from each participant during the study period, as observed by TrueLoo™ image analysis.

Secondary

MeasureTime frameDescription
Comparison with current methodologiesWeek 16 - 30Error rate of bowel movement and urinary event tracking from current caregiver-reported and self-reported methods.

Other

MeasureTime frameDescription
Identification of anomalous toileting patterns in TrueLoo™ dataWeek 16 - 30Number of bowel movement and urinary event anomalies observed by TrueLoo™; ad-hoc health history collection and urine sampling will determine the relevance of these events.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026